# Pharmacokinetics and Hepatic Safety of EGCG

> **NCT04177693** · PHASE1 · COMPLETED · sponsor: **Yale University** · enrollment: 39 (actual)

## Conditions studied

- Uterine Fibroids

## Interventions

- **DIETARY_SUPPLEMENT:** Epigallocatechin gallate (EGCG)
- **DRUG:** Clomiphene Citrate
- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT04177693
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-24
- **Primary completion:** 2022-01-31
- **Final completion:** 2022-01-31
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2023-06-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04177693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04177693, "Pharmacokinetics and Hepatic Safety of EGCG". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04177693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*